Table 2 RASSF1A methylation status according to pathological stage

From: Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

Stage

RASSF1A methylated

RASSF1A unmethylated

Total

IA

5

6

11

IB

13

3

16

IC

10

4

14

IIA

2

0

2

IIB

6

2

8

IIIA

6

0

6

Back to article page